Ostacolo Carmine
Pharmaceutical Chemistry Researcher
Department of Pharmacy
University Federico II
Italy
Biography
03/2000 Degree in Pharmaceutical Chemistry and Technology (CTF), Faculty of Pharmacy, University of Naples Federico II 12/2004 Ph.D. in Pharmaceutical Sciences, Faculty of Pharmacy, University of Naples Federico II 2004-2006 Postdoctoral Research Period, Faculty of Pharmacy, University of Naples Federico II B. Role in international institutions 2009-201 0 Visiting Recipe, Procter & Gamble Eurocor, Brussels (Belgium) 2011-2012 Recipient visiting Fraunhofer-Gesellschaft Institute, Bremen (Germany) C. Professional roles and occupations 2000-2001 Scholarship, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Salerno, 2007-2017 Professor Aggregate, Department of Pharmacy, University of Naples Federico II 2016: Contract Professor, Department of Agriculture, Mediterranean University of Reggio Calabria 2014 Contract Professor, Mediterranean Foundation Terina, Lamezia Terme (CZ) 2006- to today IT Researcher, Department of Pharmacy, University of Naples Federico II 2012-2013 Visiting Researcher, Pharmacotherapy of Pharmaceutical Sciences University of Perugia
Research Interest
Dr. Hazard's main research activity focuses on the synthesis and characterization of small molecules and pharmacological peptides. In conjunction with canonical synthetic approaches, this research is based on the development of alternative synthetic methods such as microwave assisted synthesis and continuous flow chemistry. The main current search lines are represented by: 1) Potassium KCNQ dependent voltage channels 2) TRPM Channel Modulators 3) Antitumor agents on chinoma, on glucose metabolism, on modulation of p53
Publications
-
Customized Corneal Cross-Linking-A Mathematical Model
-
Development of an improved online comprehensive hydrophilic interaction chromatography × reversed-phase ultra-high-pressure liquid chromatography platform for complex multiclass polyphenolic sample analysis
-
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from fragment Virtual Screening